Research Article

Novel LC Method Development and Validation for Simultaneous Determination of Montelukast and Doxofylline in Bulk and Pharmaceutical Dosage Forms

Table 3

Results for the accuracy of the method.

Initial conc areaSol 1 area50% areaSol 1-50% area%Recovery

Sol 1Montelukast49450678565329551829117798.53
Doxofylline10344817165260646302308618124799.56

Initial conc areaSol 2 area100% areaSol 2-75% area%Recovery

Sol 2Montelukast49450698841849450649391299.88
Doxofylline10344817207870921034481710442275100.94

Initial conc areaSol 3 area150% areaSol 3-100% area%Recovery

Sol 3Montelukast494506120187571226470736999.31
Doxofylline10344817250468501453783514702033101.13